Clinical Trial Update: High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose thiotepa, busulfan, and cyclophosphamide followed by autologous stem cell transplantation in Central Nervous System …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: TERMINATED